ID
35513
Beschrijving
Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome
Trefwoorden
Versies (1)
- 06-03-19 06-03-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
6 maart 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)
Form D
- StudyEvent: ODM
Beschrijving
Form D
Alias
- UMLS CUI-1
- C0011065
Beschrijving
Cause of Death
Datatype
text
Alias
- UMLS CUI [1]
- C0007465
Beschrijving
Date of Death
Datatype
date
Alias
- UMLS CUI [1]
- C1148348
Beschrijving
Autopsy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0004398
Beschrijving
Autopsy, Findings, Diagnosis
Datatype
text
Alias
- UMLS CUI [1,1]
- C0004398
- UMLS CUI [1,2]
- C0243095
- UMLS CUI [1,3]
- C0011900
Beschrijving
Signature of responsible attending physician on file
Datatype
text
Alias
- UMLS CUI [1]
- C0807938
Beschrijving
Signature of responsible attending physician on file, Date in time
Datatype
date
Alias
- UMLS CUI [1,1]
- C0807938
- UMLS CUI [1,2]
- C0011008
Similar models
Form D
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])